US authorises Covid-19 boosters for all adults
WASHINGTON: The United States authorised the Pfizer and Moderna Covid vaccine boosters for all people aged 18 and older on Friday, as the world’s hardest-hit country enters a new winter wave of the pandemic.
Boosters were previously available to the immune compromised, people over 65, those at high risk of severe disease, and people in high risk occupations.
The new decision “helps to provide continued protection against Covid-19, including the serious consequences that can occur, such as hospitalisation and death,” acting commissioner Janet Woodcock of the Food and Drug Administration (FDA) said.
A panel of experts convened by the Centers for Disease Control and Prevention (CDC) then ratified the decision to broaden eligibility, while explicitly recommending boosters for all people over 50, even absent underlying conditions.
“I am really glad that we have clarity and streamlining of the recommendations so that all Americans can understand the vaccines that are recommended for them at this time,” said Camille Kotton, an infectious disease clinician at Massachusetts General Hospital.
CDC director Rochelle Walensky formally signed off on the panel’s recommendations, stating that boosters “are an important public health tool to strengthen our defenses against the virus as we enter the winter holidays.”
The FDA said it based its decision on data demonstrating a strong immune response to boosters from hundreds of people dosed with both brands of vaccines.
Pfizer also carried out a clinical trial involving 10,000 people aged over 16 which found that the booster showed an efficacy against symptomatic infection of more than 95 per cent compared to those who did not receive a booster.
Both vaccines are available to people six months after completing their primary series.
Pfizer’s vaccine is dosed at 30 micrograms, the same as the primary series, while Moderna’s is 50 micrograms, half the primary series. People who received the Johnson & Johnson one-dose vaccine were already eligible for a booster of any brand two months after their first shot.
The booster decision comes as cases are rapidly rising nationally, reaching 88,000 new infections per day on average as the country enters its fifth wave, according to the latest data.
America is officially the pandemic’s hardest-hit country, with more than 760,000 deaths.